Therapeutic effect of sentinel lymph node biopsy in melanoma remains an open question

Journal of Clinical Oncology

Volumn 27, Issue 26, 2009, Pages 4236-4238

  Gimotty, Phyllis A ^a   Yoon, Frank ^b   Hammond, Rachel ^c   Rosenbaum, Paul ^b   Guerry, DuPont ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CANCER REGISTRY; CANCER SURVIVAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MICROMETASTASIS; NOTE; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; THERAPY EFFECT; ARTICLE; LYMPHADENECTOMY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 70349313366     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.4518     Document Type: Note

References (10)

1. Veronesi U, Adamus J, Bandiera DC, et al: Delayed regional lymphnode dissection in stage I melanoma of the skin of the lower extremities. Can 49:2420-2430, 1982
2. Sim FH, Taylor WF, Ivins JC, et al: A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer 41:948:956, 1978
3. Cascinelli N, Morabito A, Santinami M, et al: Immedicate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial. Lancet 351:793-796, 1998
4. Balch CM, Soong S, Ross MI, et al: Long-term results of a multiinstitutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Ann Surg Onc 7:87-97, 2000
5. Morton DL, Thompson JF, Cochran AJ, et al: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307-1317, 2006
6. Surveillance, Epidemiology, and End Results (SEER) Program Limited-Use Data (1973-2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008. www.seer.cancer.gov
7. Rosenbaum PR, Rubin DB: Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. The American Statistician 39:33-38, 1985
8. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 70:41-55, 1983
9. Gimotty PA, Yoon F, Hammond R, et al: Sentinel lymph node biopsy (SLNB) improves survival among SEER patients with melanoma. J Clin Oncol 26:817s, 2005 (abstr 9005)
10. SEER Program Code Manual (ed 3), 1998. http://seer.cancer.gov/tools/ condingmanuals/historical.html